stars 1 stars 2 stars 3

Partnering to Advance Human Health A unique culture delivering exceptional solutions: Almac is a financially secure, privately owned organisation with 7,000 employees globally. 600+ companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 50 years. Our vast range of services include: Biomarker Discovery & Development: Pre-clinical biomarker discovery, through to full companion diagnostic development and clinical test delivery from our CLIA lab. API Services & Chemical Development: Services for all stages of drug development for small molecules, potent and cytotoxic compounds and peptides. Pharmaceutical Development: Developing clinical candidates into an optimum formulation and manufacturing drug product for all phases of clinical trial supply. Analytical Services: Delivering comprehensive solutions supporting drug substance and product development programmes. Clinical Trial Supply: Comprehensive global clinical supply chain solutions providing physical resources and supportive technologies ensuring your clinical supply chain continually delivers across the globe. Clinical Technologies: Providing randomisation and trial supply management technology, electronic Clinical Outcome Assessments (eCOA), patient alerts and reminders, data integration and biostatistical consulting services. Commercial Services: Providing commercial manufacturing and packaging solutions and supporting commercial product launch. Find out about our exceptional career opportunities: and join our talent network

View Top Employees from Almac Group
Revenue $1.57 billion
Employees 4,225 (4,045 on RocketReach)
Founded 1968
Phone +44 28 3833 2200
JavaScript, HTML, PHP +149 more (view full list)
Category Pharmaceutical Manufacturing, Pharmaceuticals, Pharmaceutical, Pharmaceutical development services, Healthcare, Health Care, Clinical trial supply & management, Diagnostics & biomarker discovery, API services & Chemical Development, Formulation & analytical development, Commercial manufacture, Companion Diagnostics, IRT & eCRA
Competitors Bilcare Limited, Catalent Pharma Solutions, NextPharma, PPD, Recipharm
SIC 283, 28
NAICS 32, 325, 62, 325413, 3254, 621, 62151, 32541, 6215

Almac Group Questions

The Almac Group annual revenue was $1.57 billion in 2023.

Mark Weir is the Vice President Finance US - Group of Almac Group.

4,045 people are employed at Almac Group.

The NAICS codes for Almac Group are [32, 325, 62, 325413, 3254, 621, 62151, 32541, 6215].

The SIC codes for Almac Group are [283, 28].

Top Almac Group Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users